Guangdong Zhongsheng Pharmaceutical Co., Ltd.
002317
株式のランク
#4568
Guangdong Zhongsheng Pharmaceutical Co., Ltd. is a Chinese pharmaceutical... Guangdong Zhongsheng Pharmaceutical Co., Ltd. is a Chinese pharmaceutical company actively involved in the entire lifecycle of drug development, from research and development to manufacturing and commercialization. Its product portfolio encompasses both traditional Chinese medicines (TCM) and modern chemical pharmaceuticals. The company's robust research and development initiatives are directed towards creating solutions for a wide array of health conditions, specifically targeting ophthalmological, cardiovascular, cerebrovascular, respiratory, digestive, diabetic, oncological, and age-related degenerative diseases. Established in 1979, the company maintains its primary operations from its headquarters in Dongguan, China.
株価
$3.89
時価総額
$3.30B
変化（1日）
-3.14%
変化（1年）
43.11%
国
CN
取引 Guangdong Zhongsheng Pharmaceutical Co., Ltd. (002317)
カテゴリー
Healthcare
Guangdong Zhongsheng Pharmaceutical Co., Ltd.（002317）の利益
Jun 2026 時点の利益 TTM: $30.61M
Guangdong Zhongsheng Pharmaceutical Co., Ltd. の最新の財務報告によると、同社の現在の利益は $30.61M です。2024 年には $-46.02M の利益を上げ、これは 2023 年の利益 $40.07M と 減少 です。このページに表示されている利益は、利息および税引き前利益、すなわち EBIT です。
Guangdong Zhongsheng Pharmaceutical Co., Ltd. の利益の推移（2006 〜 2026）
各年末の利益
| 年 | 利益 | 変化 |
|---|---|---|
| 2026 (TTM) | $30.61M | -27.78% |
| 2025 | $42.39M | -192.12% |
| 2024 | $-46.02M | -214.83% |
| 2023 | $40.07M | -24.95% |
| 2022 | $53.39M | 9.66% |
| 2021 | $48.69M | -192.13% |
| 2020 | $-52.85M | -197.14% |
| 2019 | $54.41M | -25.14% |
| 2018 | $72.68M | -3.83% |
| 2017 | $75.58M | 8.55% |
| 2016 | $69.62M | 32.24% |
| 2015 | $52.65M | 31.36% |
| 2014 | $40.08M | 11.54% |
| 2013 | $35.94M | 5.30% |
| 2012 | $34.13M | 22.83% |
| 2011 | $27.78M | 19.74% |
| 2010 | $23.20M | 38.06% |
| 2009 | $16.81M | 34.21% |
| 2008 | $12.52M | 76.32% |
| 2007 | $7.10M | 52.00% |
| 2006 | $4.67M | 0.00% |
同業他社の利益
| 企業 | 利益 | 利益の差 | 国 |
|---|---|---|---|
| $3.62B | 11,717.83% |
DE
|
|
| $3.40B | 11,022.45% |
DE
|
|
| $1.72B | 5,530.23% |
JP
|
|
| $930.30M | 2,938.85% |
CH
|
|
| $1.69B | 5,429.10% |
IN
|
